With the introduction of an individualized approach to the management of patients with T2D, the potential value of glucose-lowering therapy involves more than a costbenefit analysis, and is based on a package of attributes that take into account long-term safety, tolerability, risk of hypoglycemia and weight gain, and suitability in the presence of comorbidities and other medications
Analytical technologies such as GC-MS and LC-MS/MS can detect compounds in urine at picogram-per-milliliter concentrations
The list price without insurance is $998 per month, similar to Ozempic
Negligence Some people accuse Novo Nordisk of not doing enough to make sure Ozempic was safe before putting it on the market
it does not improve the scoring of hepatic steatosis or fibrosis (Lyu et al
Severe, recurring, or worsening headaches should be assessed by a clinician